Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.70998 | 61 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.86755 | 65 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.92148 | 65 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.89682 | 65 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.90775 | 65 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.76922 | 62 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.20438 | 68 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.28777 | 69 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.1296 | 68 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.01012 | 66 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.89103 | 65 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.11133 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.74805 | 62 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.89544 | 65 |